menu
    • menu
    [{"orgOrder":0,"company":"Captain T Cell","sponsor":"Charles River Laboratories, Inc","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"GERMANY","productType":"Undisclosed","year":"2024","type":"Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Oncology","graph2":"Preclinical","graph3":"Captain T Cell","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Captain T Cell \/ Charles River Laboratories, Inc","highestDevelopmentStatusID":"4","companyTruncated":"Captain T Cell \/ Charles River Laboratories, Inc"},{"orgOrder":0,"company":"Captain T Cell","sponsor":"Springboard Health Angels | Pluton Asset Holding AG","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"GERMANY","productType":"Cell & Gene Therapy","year":"2025","type":"Financing","leadProduct":"CTC127","moa":"MAGE-A4","graph1":"Oncology","graph2":"Preclinical","graph3":"Captain T Cell","amount2":0.02,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0.02,"dosageForm":"Undisclosed","sponsorNew":"Captain T Cell \/ Springboard Health Angels | Pluton Asset Holding AG","highestDevelopmentStatusID":"4","companyTruncated":"Captain T Cell \/ Springboard Health Angels | Pluton Asset Holding AG"}]

    Find Clinical Drug Pipeline Developments & Deals by Captain T Cell

    Menu

    Captain T Cell

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Captain T Cell

                            Germany arrow
                            VMX
                            Not Confirmed

                            Captain T Cell

                            Germany arrow
                            VMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : CTC127

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Springboard Health Angels | Pluton Asset Holding AG

                            Deal Size : $23.1 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Captain T Cell Secures Funding to Advance Next-Gen TCR-T Pipeline to Clinic

                            Details : The financing for CTC127, a cell & gene therapy targeting MAGE-A4 in solid tumors, aims to advance cancer treatment.

                            Product Name : Undisclosed

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : Undisclosed

                            November 17, 2025

                            Lead Product(s) : CTC127

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Springboard Health Angels | Pluton Asset Holding AG

                            Deal Size : $23.1 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Captain T Cell

                            Germany arrow
                            VMX
                            Not Confirmed

                            Captain T Cell

                            Germany arrow
                            VMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Charles River Laboratories, Inc

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector Production Program Agreement

                            Details : Captain T Cell will access CDMO capabilities and advisory services as it prepares to manufacture TCR-T cell therapy for solid tumor patients in Phase 1 trials.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Undisclosed

                            June 17, 2024

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Charles River Laboratories, Inc

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.